DEED OF INDEMNITYDeed of Indemnity • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • England and Wales
REGISTRATION RIGHTS AGREEMENT dated [ ], 2013 by and among Oxford Immunotec Global PLC and certain shareholdersRegistration Rights Agreement • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • New York
DEED OF INDEMNITYDeed of Indemnity • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • England and Wales
Deed of Novation of Agreement for ServicesDeed of Novation of Agreement for Services • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances • England and Wales
This Deed of Novation of Agreement for Services is made this 8th day of November, 2013, by and between, Oxford Immunotec Limited, a company registered in England and Wales under number 4516079 (“Limited”), Oxford Immunotec Global PLC, a company registered in England and Wales under number 8654254 (“Global”), and Peter Wrighton-Smith, Ph.D., an individual residing at Pippins, Cox Lane, Stanton St. John, Oxfordshire OX33 1HW (“Dr Wrighton-Smith”).
DIRECTOR STOCK OPTION AWARD granted under Appendix B to the OXFORD IMMUNOTEC GLOBAL PLCDirector Stock Option Award • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
This agreement (this “Agreement”) evidences a stock option granted by Oxford Immunotec Global PLC (the “Company”) to the undersigned (the “Optionee”) pursuant to the Company’s 2013 Share Incentive Plan and Appendix B thereto (together, as amended from time to time, the “Plan”).
